Brussels, Belgium - (April 22, 2008)

Soy Positively Affects Markers for Metabolic Syndrome - New Data Presented at 5th International Conference Soy & Health 2008 , Ghent, Belgium - June 2 and 3, 2008

The metabolic syndrome is a clustering of metabolic abnormalities such as visceral adiposity, dyslipidemia, hypertension, and insulin resistance that occurs in individuals with impaired insulin sensitivity. Genetic, metabolic and environmental factors, including diet, are thought to play a major role in the etiology of this syndrome.

Earlier studies have reported that soy consumption can reduce the development of metabolic syndrome in rats. At the Soy & Health Conference in Ghent, Belgium, on June 2-3 data will be presented which describe therapeutic effects of soy consumption on the insulin resistance and markers of the cardiovascular risk factors in postmenopausal women with the metabolic syndrome. Inflammatory markers and markers of the oxidative stress were also reduced in these patients following soy inclusion in their diets.

This study will be presented by Dr. Leila Azadbakht, Isfahan University of Medical Sciences, Isfahan, Iran. The study was performed in collaboration with Prof. Walter C. Willett of Harvard School of Public Health, U.S.A..

This 5th International Conference Soy & Health 2008 will host participants from industry, health care professionals, government and information services. Leading soyfood producers and soy ingredient and supplement manufacturers will show the newest products and applications.

The simultaneously running 1st International Symposium Soy & Strategic Marketing brings a program for soyfood, soy ingredient, and food industry management, marketing and product developers.

Brussels, Belgium — (February 14, 2008) —

Soy protein and soy phytochemical compounds such as isoflavones has a positive impact on cardiovascular disease risk reduction

New research proves that consumption of soy protein and soy phytochemical compounds such as isoflavones has a positive impact on cardiovascular disease risk reduction, helps fighting metabolic syndrome and cancer.

This 5th International Conference Soy & Health 2008 will receive more than 300 participants from industry, health care professionals, government and information services. Leading soyfood producers and soy ingredient and supplement manufacturers will show the newest products and applications.

Soy & Health 2008 offers a unique opportunity to meet with all the leading world experts on Soy & Health. The conference will give a full review of recent developments in the field of Soy & Health. Topics include:

• Cardiovascular Disease Risk Reduction: the role of soy protein and isoflavones
• Safety of Isoflavones as phytoestrogens and effect of soy isoflavone intake on testosterone levels
• Soy and the prevention of breast and prostate cancer
• Impact of soy in the diet for diabetic and obese patients
• How to advise patients to consume soy-rich diets?

The simultaneously running 1st International Symposium Soy & Strategic Marketing brings a program for soyfood, soy ingredient, and food industry management, marketing and product developers with topics such as:

• Trends and Innovation in Functional Foods Markets – The Need for Ongoing Product Innovation
• Nutritional and Health Attributes of Soyfoods for Specific Populations
• Health and Nutrition as Major driver for new Food product Introductions
• Key trends in Food, Nutrition and Health in 2008.

Soy & Health 2008 and Soy & Strategic Marketing are organized by Soy Conference of Belgium and supported by Solae, Solbar, and Alpro Soyfoods and, with additional media sponsorship.